Daily Sepsis Research Analysis
Three impactful sepsis studies emerged today: a translational Critical Care study identifies phospholipid transfer protein (PLTP) activity as both a strong early predictor and potential therapeutic target in sepsis-associated AKI; a large MIMIC-IV cohort reveals a U-shaped association between the TyG index and 28-day mortality in sepsis; and a prospective study develops a machine-learning–guided nomogram using lymphocyte subtyping to predict intra-abdominal candidiasis in septic patients.
Summary
Three impactful sepsis studies emerged today: a translational Critical Care study identifies phospholipid transfer protein (PLTP) activity as both a strong early predictor and potential therapeutic target in sepsis-associated AKI; a large MIMIC-IV cohort reveals a U-shaped association between the TyG index and 28-day mortality in sepsis; and a prospective study develops a machine-learning–guided nomogram using lymphocyte subtyping to predict intra-abdominal candidiasis in septic patients.
Research Themes
- Translational biomarkers and therapeutic targets in sepsis-associated acute kidney injury
- Nonlinear metabolic risk markers for mortality in sepsis
- Immune phenotyping and machine learning for early fungal infection prediction in sepsis
Selected Articles
1. The role of phospholipid transfer protein in sepsis-associated acute kidney injury.
In a prospective ICU cohort (n=93) and a CLP mouse model, plasma PLTP activity within 24 hours independently predicted SA-AKI and MAKE30 (AUC 0.87 for both), with higher activity associated with fewer adverse kidney events. PLTP+/− mice had worse renal function and inflammation after CLP, while recombinant human PLTP improved 10-day survival, renal function, and mitochondrial integrity.
Impact: This study bridges human biomarker discovery with mechanistic validation and therapeutic modulation, positioning PLTP as both a prognostic marker and a druggable target in SA-AKI.
Clinical Implications: Early measurement of PLTP activity may aid risk stratification for SA-AKI and MAKE30; recombinant PLTP or agents that enhance PLTP function warrant evaluation as potential therapies.
Key Findings
- Plasma PLTP activity within 24 h predicted SA-AKI (adjusted OR 0.92 per unit; AUC 0.87).
- PLTP activity predicted MAKE30 with AUC 0.87; high-activity group had fewer adverse kidney events.
- PLTP± mice exhibited worse renal function and higher inflammatory mediators post-CLP versus wild-type.
- Recombinant human PLTP improved 10-day survival, renal function, and reduced mitochondrial injury in CLP mice.
Methodological Strengths
- Prospective cohort with serial biomarker measurements and predefined outcomes (SA-AKI, MAKE30).
- Translational validation using CLP mice including loss-of-function and recombinant protein rescue.
Limitations
- Single-center cohort with modest sample size (n=93) may limit generalizability.
- Causality in humans remains unproven; animal model findings may not fully translate.
Future Directions: External validation of PLTP as a biomarker, dose-finding and safety studies of recombinant PLTP, and trials testing PLTP-guided therapy in SA-AKI.
BACKGROUND: Phospholipid transfer protein (PLTP), a glycoprotein widely expressed in the body, is primarily involved in plasma lipoprotein metabolism. Previous research has demonstrated that PLTP can exert anti-inflammatory effects and improve individual survival in patients with sepsis and endotoxemia by neutralizing LPS and facilitating LPS clearance. However, the role of PLTP in sepsis-associated acute kidney injury (SA-AKI) and the specific mechanism of its protective effects are unclear. This study aimed to assess the potential role of PLTP in SA-AKI. METHODS: This is a population-based prospective observational study of patients with sepsis admitted to the intensive care unit. Blood samples were collected on days 1, 3, 5, and 7 after admission to the ICU. Plasma PLTP lipotransfer activity was measured to assess outcomes, including the incidence of SA-AKI and 30-day major adverse kidney events (MAKE 30). The correlation between PLTP lipotransfer activity and SA-AKI and MAKE 30 was evaluated through logistic regression modeling. Receiver operating characteristic curves were used to assess the diagnostic value of PLTP lipotransfer activity for SA-AKI and MAKE 30. The PLTP lipotransfer activity was categorized into high and low groups based on the optimal cut-off values. The differences between the high and low PLTP lipotransfer activity groups in terms of MAKE 30 were evaluated using Kaplan-Meier analysis. The SA-AKI mouse model was established via cecum ligation and puncture (CLP) in the animal experimental phase. The impact of PLTP on renal function was then investigated in wild-type and PLTP ± mice.
2. Establishment and Validation of a Machine-Learning Prediction Nomogram Based on Lymphocyte Subtyping for Intra-Abdominal Candidiasis in Septic Patients.
In 633 septic patients with intra-abdominal infection, the authors built and validated a prediction nomogram for intra-abdominal candidiasis using lymphocyte subtyping plus clinical variables. Machine-learning (random forest) guided variable selection; multivariable logistic regression underpinned the nomogram. High-dose corticosteroid exposure and CD4+ T-cell parameters emerged as important predictors; the model demonstrated good discrimination, calibration, and clinical utility.
Impact: Provides a pragmatic, immune-informed tool to identify high-risk IAC early in sepsis, potentially enabling timely antifungal therapy and source control.
Clinical Implications: Integration of lymphocyte subtyping into bedside risk models may refine antifungal stewardship, reduce delays in therapy, and prioritize diagnostics (cultures, imaging) for suspected IAC.
Key Findings
- Prospective cohort of 633 septic patients with intra-abdominal infection enabled model development and validation.
- Random forest identified key immune and clinical predictors; multivariable logistic regression constructed the nomogram.
- High-dose corticosteroid exposure and CD4+ T-cell metrics were important predictors; the model showed good discrimination, calibration, and clinical usefulness.
Methodological Strengths
- Prospective cohort with consecutive enrollment and immune phenotyping at infection onset.
- Machine-learning–assisted variable selection with multivariable modeling and model performance assessment (discrimination, calibration, clinical utility).
Limitations
- Abstract does not report external validation or specific performance metrics (e.g., AUC), limiting assessment of generalizability.
- Single-region cohort; performance in other settings and pathogen spectra remains to be tested.
Future Directions: External, multicenter validation; incorporation into EHR for real-time decision support; impact studies on antifungal timing, diagnostic yield, and outcomes.
This study aimed to develop and validate a nomogram based on lymphocyte subtyping and clinical factors for the early and rapid prediction of Intra-abdominal candidiasis (IAC) in septic patients. A prospective cohort study of 633 consecutive patients diagnosed with sepsis and intra-abdominal infection (IAI) was performed. We assessed the clinical characteristics and lymphocyte subsets at the onset of IAI. A machine-learning random forest model was used to select important variables, and multivariate logistic regression was used to analyze the factors influencing IAC. A nomogram model was constructed, and the discrimination, calibration, and clinical effectiveness of the model were verified. High-dose corticosteroids receipt, the CD4
3. Association of TyG index with mortality at 28 days in sepsis patients in intensive care from MIMIC IV database.
Among 8,955 ICU patients with sepsis, the TyG index showed a U-shaped association with 28-day mortality, with the lowest risk near a TyG of 9.03. Below this point, higher TyG correlated with lower mortality (adjusted OR 0.727), whereas above it, higher TyG correlated with higher mortality (adjusted OR 1.185); results were robust across subgroups.
Impact: Identifies a simple, routinely available metabolic marker with a nonlinear risk relationship, enabling nuanced risk stratification in sepsis.
Clinical Implications: TyG index may complement early prognostication; attention to both low and high extremes could inform metabolic optimization and monitoring strategies.
Key Findings
- Large retrospective cohort of 8,955 septic ICU patients with 18.3% 28-day mortality.
- Restricted cubic spline showed a U-shaped relationship between TyG and 28-day mortality (nonlinear P=0.0003).
- Inflection at TyG 9.03: below it, higher TyG linked to lower mortality (adjusted OR 0.727); above it, higher TyG linked to higher mortality (adjusted OR 1.185).
Methodological Strengths
- Very large sample with robust multivariable adjustment and spline modeling.
- Consistent findings across subgroup and sensitivity analyses.
Limitations
- Retrospective single-database design; residual confounding cannot be excluded.
- Observational data preclude causal inference; TyG dynamics over time were not assessed.
Future Directions: Prospective validation, assessment of TyG trajectory during ICU stay, and interventional studies testing metabolic optimization around the identified inflection.
The relationship between the triglyceride‒glucose (TyG) index and the clinical prognosis of septic patients in intensive care units (ICUs) remains unclear. This study aimed to explore the correlation between the TyG index and 28-day all-cause mortality in septic patients. A retrospective observational cohort study was conducted, including 8955 septic patients from the MIMIC IV 2.2 database. The primary outcome was 28-day all-cause mortality. Multivariate logistic regression analysis and restricted cubic spline regression analysis were used to assess the relationship between the TyG index and 28-day all-cause mortality in septic patients. Subgroup analyses and sensitivity analyses were performed to further validate the robustness of the results. A total of 8955 septic patients were included, 5219 (58.3%) of whom were male, with a mean age of 66.3 (15.8) years and an average TyG index of 9.08 (0.70) and the number of deaths within 28 days was 1639 (18.3%). The RCS curve demonstrated a U-shaped relationship between the TyG index and 28-day all-cause mortality (nonlinear P value = 0.0003). The risk of 28-day all-cause mortality was negatively associated with the TyG index until it decreased to 9.03 (adjusted odds ratio [OR] 0.727, 95% confidence interval [CI] 0.577-0.915). However, when the TyG index exceeded 9.03, the odds ratio for 28-day all-cause mortality significantly increased (adjusted OR 1.185, 95% CI 1.001-1.404). These findings were consistent across subgroups and various sensitivity analyses. Our study revealed a nonlinear U-shaped relationship between the TyG index and 28-day all-cause mortality, with a critical point at a TyG index of 9.03. Our results suggest that the TyG index may be a novel and important factor for the short-term clinical prognosis of critically ill septic patients.